- Cash
Volume Analysis
SPOT Pivot Levels
| Type | Classic | Fibonacci |
|---|---|---|
| R1 | 53.43 | 53.22 |
| R2 | 55.28 | 54.01 |
| R3 | 56.76 | 55.28 |
| PP | 51.95 | 51.95 |
| S1 | 53.43 | 53.22 |
| S2 | 48.62 | 49.89 |
| S3 | 46.77 | 48.62 |
Ratios
| Particulars | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|---|---|
| ROCE | - | 3.03 | - | 7.86 | - |
| ROE | - | 0.9 | - | 6.1 | - |
| EPS | 0.08 | -1.02 | 0.22 | 0.36 | 0.75 |
Peer Comparison
| Scrip Name | Price | Daily change | M Cap | PE Ratio | 1 Year Return |
|---|
Corporate Action
- Announcements
- Board Meetings
- Dividends
- Bonus
- Splits
- Rights
- AGM/EGM
- Credit Rating
About Lyka Labs Ltd
Initially manufacturing formulations, Lyka Labs Limited brought bulk drugs into its operational fold by amalgamating Lyphin Chemicals Pvt Ltd with itself in Apr. '83. It also added a range of ayurvedic and animal health care products over the years. In 1990, it diversified into marketing medical and diagnostic equipment and instruments of Bekton Dickinson, US; Airsep Corporation, US; Coloplast, De...
ISIN :INE933A01014
Registered Office
4801/B & 4802/A,GIDC Industrial Estate
Contact number
+ 91-02646-221422/220549
Registrars
Sharex Dynamic (India) Pvt Ltd
C-101 247 Park L B S Marg Vikhroli West Mumbai - 400083
C-101 247 Park L B S Marg Vikhroli West Mumbai - 400083
Contact number
+ 91-22-28515644/5606
Management
Babulal Jain (Chairman)
KUNAL NARENDRA GANDHI (Director)
Open IPO’s
FAQs
The share price of Lyka Labs Ltd on the BSE is - as on -